New Zealand: MacLeod to leave CEO role at Ryman Healthcare

Ryman Healthcare CEO, Gordon MacLeod, is leaving the company after 15 years in senior roles. MacLeod joined Ryman as CFO in January 2007, was appointed deputy Chief Executive at the end of 2014, and took over as CEO in June 2017. During his time as CEO, Ryman’s market capitalisation grew from NZ$4.2bn (US$3bn) to NZ$7.2bn,…

You must be a HMI Subscriber to view this content.

Subscribe Now »